Neil E Ernst

Publications35
h-index7
Citations138
Highly Influential Citations4
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Cazzola
  • 674 Publications, 13,247 Citations
  • M. Matera
  • 362 Publications, 6,264 Citations
  • T. Warkentin
  • 470 Publications, 30,081 Citations
  • L. Calzetta
  • 270 Publications, 3,788 Citations
  • Publications
  • Influence
Argatroban for anticoagulation in continuous renal replacement therapy.
To the Editor: We commend Link et al (1) on their well-designed prospective argatroban dose-finding study in a rather homogeneous critically ill population receiving continuous renal replacement… Expand
  • 15
  • 2
Utility of bilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia in critically ill surgical patients.
BACKGROUND Bronchoalveolar lavage (BAL) is recommended to facilitate the diagnosis of ventilator-associated pneumonia (VAP). It is unclear if bilateral sampling improves the accuracy of BAL. … Expand
  • 7
  • 1
Pharmacokinetics and Pharmacodynamics of Extended‐Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open‐Label Study
To evaluate extended‐infusion (EI) cefepime pharmacokinetics (PK) and pharmacodynamic target attainment in critically ill patients receiving continuous venovenous hemofiltration (CVVH) or continuous… Expand
  • 3
  • 1
Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients
BACKGROUND Low anti-factor Xa (anti-Xa) concentrations with twice-daily enoxaparin are associated with venous thromboembolism (VTE) in high-risk trauma patients. Concerns have been raised with… Expand
  • 20
Effects of Critical Illness and Organ Failure on Therapeutic Argatroban Dosage Requirements in Patients with Suspected or Confirmed Heparin-Induced Thrombocytopenia
BACKGROUND Critically ill patients often require therapeutic argatroban dosages lower than those recommended in package labeling. The magnitude of dosage alteration in relation to severity of organ… Expand
  • 29
Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs
Introduction: Phosphodiesterase (PDE) inhibitors modulate lung inflammation and cause bronchodilation by increasing intracellular cyclic adenosine 3’, 5’-monophosphate in airway smooth muscle and… Expand
  • 25
Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs
ABSTRACT Introduction: Long acting muscarinic receptor antagonists (LAMA) reverse airflow obstruction by antagonizing para-sympathetic bronchoconstricting effects within the airways. For years,… Expand
  • 13
Prevention of Perioperative Venous Thromboembolism
Venous thromboembolism (VTE) is the most common preventable cause of morbidity and mortality in postoperative patients. Overall, VTE is the second-most-common medical complication, third-mostcommon… Expand
  • 4
Ketamine versus hydromorphone patient-controlled analgesia for acute pain in trauma patients.
BACKGROUND It is unknown whether ketamine administered via patient-controlled analgesia (PCA) provides adequate analgesia while reducing opioid consumption in the traumatically injured patient.… Expand
  • 9
Impact of Norepinephrine Weight-Based Dosing Compared With Non–Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock
Obesity presents a growing challenge in critically ill patients because of variable medication pharmacokinetics and pharmacodynamics. Vasopressors used in the treatment of septic shock, including… Expand
  • 2